The catalytic domain has an RNaseH-type fold and belongs to the superfamily of polynucleotidyl transferases. The active site is comprised of two Asp.

Slides:



Advertisements
Similar presentations
Fundamentals of Biochemistry
Advertisements

Antiretroviral Drug Resistance
Antiretroviral Drug Resistance Anna Maria Geretti UCL Medical School & Royal Free Hampstead Medical School, London.
Treatment of infectious diseases. Drugs used in the treatment of bacterial diseases can be grouped into categories based on their modes of action: 1.
Lecture 13. Retroid viruses See chapter 7, and appendix 1 pp. 835 – 837. The retroviral life cycle Salient features: Viral RNA genome is reverse transcribed.
Retroviruses And retroposons
How do the Anti-HIV drugs woks? By Tawitch Suriyo Master degree of Toxicology Mahidol University.
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Hui Zhang, Bin Yang, Roger J. Pomerantz, Chune Zang, Shyamala C. Arunachalam,
Retroviruses and Retroposons
Reverse Transcription. Central Dogma Normal transcription involves synthesis of RNA from DNA. Normal transcription involves synthesis of RNA from DNA.
Combination of Drugs and Drug-Resistant Reverse Transcriptase Results in a Multiplicative Increase of Human Immunodeficiency Virus Type 1 Mutant Frequencies.
The Genetics of Viruses and Bacteria
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Anti-HIV Drugs Melissa Morgan Medicinal Chemistry November 23, 2004.
Plate 36 Retroviruses.
After a virus becomes active and replicates in a host cell, it destroys the host cell. Copies of the virus are then released into the host organism, where.
Lesson 7-3 What are Viruses?
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display The Steps in HIV Replication Slide number 1 (1) Viral.
Ahmed Yossre To Dr. Noha Khalifa. Introduction Function in viruses The process of reverse transcription Steps of creating viral DNA How does Integrase.
Which of the following statements is the most correct? 1.Viral envelopes contain both viral and host proteins 2.Viral envelopes contain glycoproteins for.
Rational Drug Design : HIV Integrase. A process for drug design which bases the design of the drug upon the structure of its protein target. 1.Structural.
The Life and Times of Anitvirals By: Karen Summers Louise Pilsbury Jasmine Delaine Irfan Mekic Bethannie Jamerson.
Medicines and drugs antivirals.
Acquired Immunodeficiency Syndrome AIDS
HIV Human Immunodeficiency Virus
New antiviral and immunoactivation compounds. Study of molecular mechanisms.
Basics of Human Immunodeficiency Virus (HIV) Brian Rybarczyk, PhD University of North Carolina- Chapel Hill.
The HIV virus. Objectives At the end of this session the participants will be able to: 1. Understand basic HIV structure 2. Describe the significance.
HIV-1 PROTEASE Presented by: Aruni karunanyake
Reverse Transcriptase (RNA-dependent DNA Polymerase)
Viruses What are the 3 main characteristics of viruses? What are the 3 components of a virus’s structure? What is important about the viral envelope? The.
Antivirals Essential idea
Enzyme Inhibition in the Treatment of AIDS
Annual Health Insurance Premiums And Household Income,
Warm-Up (12/01) On the piece of white paper from the back, answer the following question. Name Date Period How did the Hershey-Chase experiment prove.
Of drug cocktails and inhibited enzymatic rates
Antivirals Essential idea
Treatment of Infectious Diseases
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Human Health and Disease
Biology Copyright Pearson Prentice Hall.
Protease.
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
Structure and Function Laura Martin
Rational Drug Design : HIV Integrase
Structure and Function Laura Martin
Structure and Function Laura Martin
Introduction to antibacterial drugs
Michelle L. Holmes-Son, Samson A. Chow  Molecular Therapy 
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
MG132 allows extensive RT of HIV-1 cDNA despite exogenous rhTRIM5α.
Volume 93, Issue 5, Pages (May 1998)
Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis  Marcin Nowotny, Sergei A. Gaidamakov, Robert.
The TRIM Family Protein KAP1 Inhibits HIV-1 Integration
Figure 2. Technique overview
Investigate the Treatment of Infectious Diseases
Double Trouble: HIV Latency and CTL Escape
Volume 13, Issue 3, Pages (March 2006)
Volume 15, Issue 3, Pages (April 2016)
Volume 39, Issue 6, Pages (December 2013)
Volume 15, Issue 11, Pages (November 2007)
Investigate the Treatment of Infectious Diseases
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis  Marcin Nowotny, Sergei A. Gaidamakov, Robert.
KEY CONCEPT Some viral diseases can be prevented with vaccines.
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Xiaowu Gai, Daniel F. Voytas  Molecular Cell 
Research Rational Drug Design: A process for drug design which bases the design of the drug upon the structure of its protein target. Structural mapping.
Alignment of the Amino Acid Sequences of NCS and Other PR10/Bet v1 Proteins from Various Plant Species.Deduced amino acid sequences were aligned using.
Presentation transcript:

The catalytic domain has an RNaseH-type fold and belongs to the superfamily of polynucleotidyl transferases. The active site is comprised of two Asp residues and one Glu, in the typical DDE motif, each of which is required for catalysis.

four criteria to conclude that integrase is theinhibitor target: 1. found to be active against recombinant integrase. 2. infected cells treated with the drug must show an accumulation of 2-LTR circles, resulting from the accumulation of viral cDNA and decreased HIV integration into host 3. integrase mutations must be found in drug-resistant viruses 4, the drug should be inactive in biochemical assays against recombinantintegrases bearing the mutations identified in the drug-resistant viruses DKAs DCQ acids; DCT acids PDP SQL Quinolone derived